Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis.
about
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentinThe serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigensAntibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitisIdentification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritisSurface α-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic targetProtective properties and surface localization of Plasmodium falciparum enolaseRhamnose Links Moonlighting Proteins to Membrane Phospholipid in MycoplasmasProteomic surveillance of autoantigens in relapsing polychondritis.Human body fluid proteome analysis.A new target for autoantibodies in patients with rheumatoid arthritis.Bovine neonatal pancytopenia--comparative proteomic characterization of two BVD vaccines and the producer cell surface proteome (MDBK).Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes.Impact of Autoantibodies against Glycolytic Enzymes on Pathogenicity of Autoimmune Retinopathy and Other Autoimmune DisordersSeroreactivity against glycolytic enzymes in inflammatory bowel disease.Highly selective and sensitive enrichment of phosphopeptides via NiO nanoparticles using a microwave-assisted centrifugation on-particle ionization/enrichment approach in MALDI-MS.Primary biliary cirrhosis: what do autoantibodies tell us?Periodontitis, Porphyromonas, and the pathogenesis of rheumatoid arthritis.Mycoplasma synoviae enolase is a plasminogen/fibronectin binding proteinT-cell metabolism in autoimmune disease.Identification of CM1 as a Pathogenic Factor in Inflammatory Diseases and Cancer.Anti-α-enolase Antibodies in Serum from Pediatric Patients Affected by Inflammatory Diseases: Diagnostic and Pathogenetic Insights.The danger model approach to the pathogenesis of the rheumatic diseases.An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of Autoantibodies.Association between anti-Porphyromonas gingivalis or anti-α-enolase antibody and severity of periodontitis or rheumatoid arthritis (RA) disease activity in RA.Prophylactic Injection of Recombinant Alpha-Enolase Reduces Arthritis Severity in the Collagen-Induced Arthritis Mice ModelCharacterization of proteins regulated by interleukin-4 in 3T3-L1 adipocytes.Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cellsDiscovery of serum proteomic biomarkers for prediction of response to moxibustion treatment in rats with collagen-induced arthritis: an exploratory analysis.Externalized glycolytic enzymes are novel, conserved, and early biomarkers of apoptosisThe Anti-inflammatory Effect of GV1001 Mediated by the Downregulation of ENO1-induced Pro-inflammatory Cytokine Production.Use of proteomics in analysis of autoimmune diseases.An update on Behçet's disease.Soluble alpha-enolase activates monocytes by CD14-dependent TLR4 signalling pathway and exhibits a dual function.Interaction of aldehydes derived from lipid peroxidation and membrane proteinsClues to the etiology of bile duct injury in biliary atresiaMethodology and applications of disease biomarker identification in human serum.Using proteomics to identify targets of antiendothelial cell antibodies.Glycolysis and rheumatoid arthritis.α-Enolase, a multifunctional protein: its role on pathophysiological situationsBiomarkers of rheumatoid arthritis: recent progress.
P2860
Q21195679-7C965DB8-0B5B-4C42-AAC0-163DDE2F4AD7Q24646963-EB46A8E4-25B6-4820-B257-B090B0FB9491Q24798067-034A17A3-0C4F-4BBD-B2CE-3DDA70C9126EQ24813085-FFB8B14E-B537-47D5-8808-872AD0A3FCCFQ27311163-E53CCA74-1700-46FD-B249-B7A730CC8301Q27973862-085DC7B9-2631-4801-9ED8-BF269FE4371CQ28553924-8005738D-7218-479D-B96F-B6D87BA0577AQ33234402-0398F53B-D86E-47DE-A279-96B7B302C2BFQ33262623-9471C1E5-43E4-4EDE-8B3C-057947C699AEQ33300254-C8951F7F-C050-45C2-818D-63C0246DFFA7Q33405446-7DC9E387-4EA3-4755-8B30-4A5EC0C9F76FQ33417857-095DED40-A357-41B4-B4AF-7053ECA677B8Q33611455-975E90C4-F9F3-4995-B10F-168668A953B3Q33632430-1F57581F-7D62-4646-BC9F-BA3B8FB5C7A2Q33887054-3E2EB93A-3AB4-423D-BE99-AAD38CFA865AQ34041388-B37897DB-2E28-4785-9CC8-41DC0E580BEFQ34249471-EF803AFD-28D0-4EA7-9610-7E340C988446Q34306874-D7815672-4CC3-4AE3-97A5-9A81B615C41AQ35071556-644E591F-F35D-41BF-87A4-9AE9A5937479Q35157035-7C099AEE-603F-4D92-AC12-8CEFE58AC45FQ35295014-17D78DA3-BCA9-4479-83B5-4D8E71010514Q35564107-E1102526-C5AD-4425-9945-05368ED202ECQ35680148-4B01FB38-0F89-492B-A295-62BCA0DED5D2Q35743329-777235A5-6A66-48BB-A026-46DF7A063D79Q35753838-E120C87A-EEED-4382-A276-E8E1DCC44E01Q35763035-39F32E9F-BEF4-48E8-A7A8-FF0EC67C6B3AQ35793730-2D9F3556-C618-413A-A358-ECEA8433A134Q35833797-BB34F11C-9B78-45E8-B666-2598109B0F6DQ35880023-983F0EDB-453C-4B9C-B6A4-CFDDEA02F61CQ36427736-56664E81-4F41-451F-A9D0-AA948AE481D7Q36560792-EF1691CB-99E3-48DC-AC79-5261EBAA395EQ36701009-76CBCE9F-DD23-4CC0-9BF7-756D382D83D9Q36776946-FEC7083C-59D6-466F-BA5A-BA7B0D92C377Q37142547-102375D8-53E1-4AEE-860E-AEDCC1726EECQ37308079-A4BCDF1B-12E8-4E07-8006-004224B1D3F0Q37574961-8ADFD7D0-F3A8-4CF1-BAC7-F5F2D2CC2C94Q37754823-7F72B576-92A9-4516-B2EE-3772833EF0FEQ37911558-B35DFEB5-14E0-4055-917A-EF506BD57A3DQ38057216-304A9B44-AD4F-44D8-83D2-88CE94E48921Q38089869-629A0362-BDBA-4B9D-ACC3-1FE9031405B1
P2860
Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Presence of autoantibodies to ...... th early rheumatoid arthritis.
@ast
Presence of autoantibodies to ...... th early rheumatoid arthritis.
@en
type
label
Presence of autoantibodies to ...... th early rheumatoid arthritis.
@ast
Presence of autoantibodies to ...... th early rheumatoid arthritis.
@en
prefLabel
Presence of autoantibodies to ...... th early rheumatoid arthritis.
@ast
Presence of autoantibodies to ...... th early rheumatoid arthritis.
@en
P2093
P2860
P356
P1476
Presence of autoantibodies to ...... th early rheumatoid arthritis.
@en
P2093
Catherine Lange
Danièle Gilbert
François Tron
Laure Marvin
Nadine Machour
Olivier Vittecoq
Patrice Fardellone
Roland Charlionet
Vincent Saulot
P2860
P304
P356
10.1002/ART.10252
P577
2002-05-01T00:00:00Z